Literature DB >> 18818283

Unique ERalpha cistromes control cell type-specific gene regulation.

Susan A Krum1, Gustavo A Miranda-Carboni, Mathieu Lupien, Jerome Eeckhoute, Jason S Carroll, Myles Brown.   

Abstract

Estrogens play an important role in normal physiology and in a variety of pathological states involving diverse tissues including breast and bone. The mechanism by which estrogens exert cell type- and disease-specific effects, however, remains to be explained. We have compared the gene expression profile of the MCF7 breast cancer cell line with that of the osteoblast-like cell line U2OS-ERalpha by expression microarrays. We find that fewer than 10% of the 17beta-estradiol (E2)-regulated genes are common to both cell types. We have validated this in primary calvarial osteoblasts. To dissect the mechanism underlying the cell type-specific E2 regulation of gene expression in MCF7 and U2OS-ERalpha cells, we compared the ERalpha binding sites on DNA in the two cell types by performing chromatin immunoprecipitation (ChIP) on genomic tiling arrays (ChIP-on-chip). Consistent with the distinct patterns of E2-regulated gene expression in these two cell lines, we find that the vast majority of ERalpha binding sites are also cell type specific and correlate both in position and number with cell type-specific gene regulation. Interestingly, although the forkhead factor FoxA1 plays a critical role in defining the ERalpha cistrome in MCF7 cells, it is not expressed in U2OS-ERalpha cells, and forkhead motifs are not enriched in the ERalpha cistrome in these cells. Finally, the ERalpha cistromes are correlated with cell type-specific epigenetic histone modifications. These results support a model for the cell type-specific action of E2 being driven primarily through specific ERalpha occupancy of epigenetically marked cis-regulatory regions of target genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818283      PMCID: PMC2582540          DOI: 10.1210/me.2008-0100

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  51 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice.

Authors:  A Plant; J H Tobias
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

Review 3.  Vitamin D control of osteoblast function and bone extracellular matrix mineralization.

Authors:  J P van Leeuwen; M van Driel; G J van den Bemd; H A Pols
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2001       Impact factor: 1.807

Review 4.  Tissue-specific estrogen biosynthesis and metabolism.

Authors:  E R Simpson; C Clyne; C Speed; G Rubin; S Bulun
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

5.  Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.

Authors:  Q Qu; M Perälä-Heape; A Kapanen; J Dahllund; J Salo; H K Väänänen; P Härkönen
Journal:  Bone       Date:  1998-03       Impact factor: 4.398

6.  Molecular determinants for the tissue specificity of SERMs.

Authors:  Yongfeng Shang; Myles Brown
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

7.  Unraveling estrogen action in osteoporosis.

Authors:  Susan A Krum; Myles Brown
Journal:  Cell Cycle       Date:  2008-02-29       Impact factor: 4.534

8.  Active genes are tri-methylated at K4 of histone H3.

Authors:  Helena Santos-Rosa; Robert Schneider; Andrew J Bannister; Julia Sherriff; Bradley E Bernstein; N C Tolga Emre; Stuart L Schreiber; Jane Mellor; Tony Kouzarides
Journal:  Nature       Date:  2002-09-11       Impact factor: 49.962

9.  Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

Authors:  S Kousteni; J R Chen; T Bellido; L Han; A A Ali; C A O'Brien; L Plotkin; Q Fu; A T Mancino; Y Wen; A M Vertino; C C Powers; S A Stewart; R Ebert; A M Parfitt; R S Weinstein; R L Jilka; S C Manolagas
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

10.  Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway.

Authors:  X W Chen; S C Garner; J J B Anderson
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

View more
  75 in total

1.  Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.

Authors:  Natalie E Simpson; Jason Gertz; Keren Imberg; Richard M Myers; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.

Authors:  Ty C Voss; R Louis Schiltz; Myong-Hee Sung; Paul M Yen; John A Stamatoyannopoulos; Simon C Biddie; Thomas A Johnson; Tina B Miranda; Sam John; Gordon L Hager
Journal:  Cell       Date:  2011-08-11       Impact factor: 41.582

3.  Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.

Authors:  Martina I Lefterova; David J Steger; David Zhuo; Mohammed Qatanani; Shannon E Mullican; Geetu Tuteja; Elisabetta Manduchi; Gregory R Grant; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

4.  Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.

Authors:  Jérôme Eeckhoute; Mathieu Lupien; Clifford A Meyer; Michael P Verzi; Ramesh A Shivdasani; X Shirley Liu; Myles Brown
Journal:  Genome Res       Date:  2009-01-07       Impact factor: 9.043

5.  Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.

Authors:  Ashlee R Lain; Chad J Creighton; Orla M Conneely
Journal:  Mol Endocrinol       Date:  2013-08-26

Review 6.  Insights from genomic profiling of transcription factors.

Authors:  Peggy J Farnham
Journal:  Nat Rev Genet       Date:  2009-08-11       Impact factor: 53.242

7.  Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.

Authors:  Päivi Pihlajamaa; Biswajyoti Sahu; Lauri Lyly; Viljami Aittomäki; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2014-01-22       Impact factor: 11.598

8.  GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.

Authors:  Aysha B Khalid; Alexandria V Slayden; Jerusha Kumpati; Chanel D Perry; Stuart B Berryhill; Julie A Crawford; Iram Fatima; Marco Morselli; Matteo Pellegrini; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Bone       Date:  2018-07-19       Impact factor: 4.398

9.  Selective coregulator function and restriction of steroid receptor chromatin occupancy by Hic-5.

Authors:  Rajas Chodankar; Dai-Ying Wu; Daniel S Gerke; Michael R Stallcup
Journal:  Mol Endocrinol       Date:  2015-03-12

10.  GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways.

Authors:  Miriam Güemes; Alejandro J Garcia; Diana Rigueur; Stephanie Runke; Weiguang Wang; Gexin Zhao; Victor Hugo Mayorga; Elisa Atti; Sotirios Tetradis; Bruno Péault; Karen Lyons; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.